scholarly article | Q13442814 |
P50 | author | Marian Rewers | Q30501357 |
David M Maahs | Q88991776 | ||
Janet K Snell-Bergeon | Q107143200 | ||
P2093 | author name string | Robert H Eckel | |
David Howard | |||
Bryan C Bergman | |||
Leigh Perreault | |||
Irene E Schauer | |||
P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
Cellular mechanisms of insulin resistance | Q29619549 | ||
Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). | Q30434577 | ||
Insulin resistance and cardiovascular disease | Q34011027 | ||
Glucose clamp technique: a method for quantifying insulin secretion and resistance | Q34191986 | ||
Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study | Q34448739 | ||
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus | Q34541876 | ||
Insulin resistance in type 1 diabetes | Q34733637 | ||
Molecular understanding of hyperglycemia's adverse effects for diabetic complications | Q35005662 | ||
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 | ||
Diagnosis of fatty liver disease: is biopsy necessary? | Q35110258 | ||
Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine | Q35766893 | ||
Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes | Q36078595 | ||
Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes | Q36756469 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. | Q37142827 | ||
Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus | Q37366705 | ||
Insulin resistance in skeletal muscles of patients with diabetes mellitus | Q38679694 | ||
Deficiencies of cardiovascular risk prediction models for type 1 diabetes | Q40302948 | ||
Can clinical factors estimate insulin resistance in type 1 diabetes? | Q40759534 | ||
Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro | Q42458341 | ||
Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study | Q43435231 | ||
Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes | Q44559076 | ||
Intensive versus conventional glucose control in critically ill patients | Q46076336 | ||
Comparison of methods for achieving 24-hour energy balance in a whole-room indirect calorimeter | Q47834620 | ||
Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. | Q51382819 | ||
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. | Q51466282 | ||
Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. | Q51633153 | ||
Natural course of insulin resistance in type I diabetes. | Q51633221 | ||
Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. | Q51649670 | ||
Calculation of substrate oxidation rates in vivo from gaseous exchange. | Q52703700 | ||
Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus. | Q54243448 | ||
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. | Q54331721 | ||
Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients | Q68034011 | ||
Alterations in glucose metabolism during menstrual cycle in women with IDDM | Q68074221 | ||
Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients | Q68100661 | ||
Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates | Q68161753 | ||
Insulin resistance is a prominent feature of insulin-dependent diabetes | Q71477121 | ||
Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle | Q73408082 | ||
Diabetic retinopathy | Q80795176 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type-1 diabetes | Q124407 |
insulin resistance | Q1053470 | ||
P304 | page(s) | 1663-1672 | |
P577 | publication date | 2012-02-22 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes | |
P478 | volume | 97 |
Q35916487 | Adiponectin-SOGA Dissociation in Type 1 Diabetes. |
Q90286903 | Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling |
Q64947889 | Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance? |
Q35077618 | De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals |
Q35004291 | Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance |
Q39375164 | Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis |
Q37597010 | Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. |
Q64271837 | HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey |
Q42759522 | Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance |
Q30583410 | Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey. |
Q37276007 | Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. |
Q36104684 | Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes |
Q51249806 | Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome. |
Q38642435 | Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes |
Q27000205 | Insulin sensitivity and complications in type 1 diabetes: New insights |
Q34194600 | Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes |
Q36951888 | Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes |
Q35531487 | Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration |
Q33816920 | Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation |
Q64055922 | Maternal genetic contribution to pre-pregnancy obesity, gestational weight gain, and gestational diabetes mellitus |
Q42774876 | Metabolomic Response of Skeletal Muscle to Aerobic Exercise Training in Insulin Resistant Type 1 Diabetic Rats |
Q34336580 | Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. |
Q92784064 | Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes |
Q36637876 | Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined |
Q41301765 | Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus |
Q98566249 | Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers |
Q39016504 | Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers |
Q38176677 | Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice |
Q55420946 | Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls. |
Q90429872 | Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions |
Q45408176 | Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes |
Q46596220 | Protein and fat meal content increase insulin requirement in children with type 1 diabetes - Role of duration of diabetes |
Q64116042 | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
Q37732357 | Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes |
Q49962054 | Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort |
Q36508961 | The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes |
Q92863320 | Urocortin 2 Gene Transfer Improves Glycemic Control and Reduces Retinopathy and Mortality in Murine Insulin Deficiency |
Q48045198 | Why should people with type 1 diabetes exercise regularly? |
Q90312756 | Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance |
Q90613030 | Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance |
Search more.